![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 11, 2005.
Revised April 28, 2005.
Accepted for publication May 3, 2005.
B DNA-
BINDING ACTIVITY BY DITERPENOIDS ISOLATED FROM ISODON
RUBESCENS
The development of specific inhibitors that can block NF-
B activation is an approach for the treatment of cancer, autoimmune and inflammatory diseases. Several diterpenoids, oridonin, ponicidin, xindongnin A and xindongnin B were isolated from an herb, Isodon rubescens. These compounds were found to be potent inhibitors of NF-
B transcription activity as well as the expression of its downstream targets, COX-2 and iNOS. The mechanisms of action of the diterpenoids against NF-
B are similar but significant differences were also identified. All the diterpenoids directly interfere with the DNA-binding activity of NF-
B to its response DNA sequence. Oridonin and ponicidin have an additional impact on the translocation of NF-
B from the cytoplasm to nuclei without affecting I
B-
phosphorylation and degradation. The effect of these compounds on the interaction of NF-
B with consensus DNA sequences is unique. Different inhibitory effects were observed when NF-
B bound to various DNA sequences. Both p65:p65 and p50:p50 homodimers, as well as p65:p50 heterodimer association with their responsive DNA were inhibited. Kinetic studies on NF-
B-DNA interaction indicate that the diterpenoids decrease the Bmax app but have no effect on Kd app. This suggests that this class of compounds interact with both p65 and p50 subunits at a site other than the DNA-binding site and subsequently modulate the binding affinity of the transcription factor towards DNA with different NF-
B binding sequences. The diterpenoid structure could therefore serve as a scaffold for the development of more potent and selective NF-
B inhibitors that target regulated gene transcription.
Key words:
Nitric oxide synthases, Tumor necrosis factor, NFkappaB, Fluorescence techniques, Regulation of gene expression, Cyclooxygenases, Transcription targets
This article has been cited by other articles:
![]() |
A. Moussaieff, E. Shohami, Y. Kashman, E. Fride, M. L. Schmitz, F. Renner, B. L. Fiebich, E. Munoz, Y. Ben-Neriah, and R. Mechoulam Incensole Acetate, a Novel Anti-Inflammatory Compound Isolated from Boswellia Resin, Inhibits Nuclear Factor-{kappa}B Activation Mol. Pharmacol., December 1, 2007; 72(6): 1657 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-B. Zhou, H. Kang, L. Wang, L. Gao, P. Liu, J. Xie, F.-X. Zhang, X.-Q. Weng, Z.-X. Shen, J. Chen, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo Blood, April 15, 2007; 109(8): 3441 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Leung, S. P. Grill, W. Lam, W. Gao, H.-D. Sun, and Y.-C. Cheng Eriocalyxin B Inhibits Nuclear Factor-{kappa}B Activation by Interfering with the Binding of Both p65 and p50 to the Response Element in a Noncompetitive Manner Mol. Pharmacol., December 1, 2006; 70(6): 1946 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, D. Chen, Q. C. Cui, X. Yuan, and Q. P. Dou Celastrol, a Triterpene Extracted from the Chinese "Thunder of God Vine," Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice. Cancer Res., May 1, 2006; 66(9): 4758 - 4765. [Abstract] [Full Text] [PDF] |
||||